Monsanto Company (MON) Receives $114.61 Average PT from Analysts

Monsanto Company (NYSE:MON) has received an average recommendation of “Buy” from the twenty-four brokerages that are presently covering the firm. One investment analyst has rated the stock with a sell rating, eight have issued a hold rating and fourteen have assigned a buy rating to the company. The average twelve-month target price among brokers that have issued ratings on the stock in the last year is $118.41.

Several brokerages have issued reports on MON. Vetr upgraded Monsanto Company from a “hold” rating to a “buy” rating and set a $118.00 price objective for the company in a research report on Wednesday, March 15th. Jefferies Group LLC restated a “buy” rating and set a $128.00 target price on shares of Monsanto Company in a research report on Tuesday, March 28th. BMO Capital Markets restated a “buy” rating and set a $128.00 target price on shares of Monsanto Company in a research report on Wednesday, April 5th. Zacks Investment Research downgraded Monsanto Company from a “buy” rating to a “hold” rating in a research report on Tuesday, February 28th. Finally, Royal Bank of Canada restated a “hold” rating and set a $118.00 target price on shares of Monsanto Company in a research report on Tuesday, March 28th.

In other news, COO Brett D. Begemann sold 80,940 shares of the company’s stock in a transaction dated Monday, April 17th. The stock was sold at an average price of $116.13, for a total transaction of $9,399,562.20. Following the completion of the transaction, the chief operating officer now directly owns 148,247 shares of the company’s stock, valued at $17,215,924.11. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Hugh Grant sold 149,230 shares of the company’s stock in a transaction dated Monday, April 10th. The stock was sold at an average price of $116.15, for a total value of $17,333,064.50. Following the transaction, the chief executive officer now directly owns 390,373 shares of the company’s stock, valued at $45,341,823.95. The disclosure for this sale can be found here. Over the last three months, insiders sold 249,540 shares of company stock valued at $28,947,034. Insiders own 0.79% of the company’s stock.

Several hedge funds and other institutional investors have recently bought and sold shares of MON. First PREMIER Bank boosted its position in Monsanto Company by 4.2% in the first quarter. First PREMIER Bank now owns 901 shares of the basic materials company’s stock valued at $102,000 after buying an additional 36 shares in the last quarter. Whitnell & Co. boosted its position in Monsanto Company by 35.4% in the first quarter. Whitnell & Co. now owns 979 shares of the basic materials company’s stock valued at $111,000 after buying an additional 256 shares in the last quarter. Hartford Financial Management Inc. purchased a new position in Monsanto Company during the first quarter valued at $113,000. Mascoma Wealth Management LLC purchased a new position in Monsanto Company during the fourth quarter valued at $115,000. Finally, JNBA Financial Advisors boosted its position in Monsanto Company by 24.6% in the fourth quarter. JNBA Financial Advisors now owns 1,148 shares of the basic materials company’s stock valued at $121,000 after buying an additional 227 shares in the last quarter. 75.18% of the stock is owned by institutional investors.

WARNING: This report was originally posted by BBNS and is the sole property of of BBNS. If you are accessing this report on another site, it was illegally copied and reposted in violation of US and international trademark and copyright law. The correct version of this report can be viewed at https://baseballnewssource.com/markets/brokerages-set-monsanto-company-mon-price-target-at-114-61-updated-updated/525761.html.

Monsanto Company (NYSE:MON) traded down 0.19% during mid-day trading on Monday, reaching $115.50. 2,055,180 shares of the company’s stock were exchanged. The company has a market capitalization of $50.68 billion, a P/E ratio of 26.57 and a beta of 0.93. The company’s 50 day moving average price is $114.50 and its 200-day moving average price is $107.42. Monsanto Company has a 52 week low of $88.76 and a 52 week high of $116.60.

Monsanto Company (NYSE:MON) last issued its quarterly earnings data on Wednesday, April 5th. The basic materials company reported $3.19 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $2.79 by $0.40. Monsanto Company had a return on equity of 47.05% and a net margin of 11.61%. The firm earned $5.07 billion during the quarter, compared to the consensus estimate of $4.73 billion. During the same quarter in the previous year, the company posted $2.42 EPS. The business’s revenue for the quarter was up 12.0% compared to the same quarter last year. On average, equities research analysts expect that Monsanto Company will post $4.90 earnings per share for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Friday, April 28th. Shareholders of record on Friday, April 7th will be paid a $0.54 dividend. The ex-dividend date of this dividend is Wednesday, April 5th. This represents a $2.16 dividend on an annualized basis and a yield of 1.87%. Monsanto Company’s payout ratio is 58.86%.

Monsanto Company Company Profile

Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.

5 Day Chart for NYSE:MON

Receive News & Ratings for Monsanto Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Company and related companies with our FREE daily email newsletter.

 

Latest News

Sources Say Luis Robert Will Be Cleared by May 20 to Sign
Sources Say Luis Robert Will Be Cleared by May 20 to Sign
Colorado Rockies Bullpen Helping Them to NL West Lead
Colorado Rockies Bullpen Helping Them to NL West Lead
Hall of Famer Given New Lease on Life
Hall of Famer Given New Lease on Life
New York Mets Have the Power
New York Mets Have the Power
Red Sox Fighting Through Illness and Injury
Red Sox Fighting Through Illness and Injury
Cleveland and Arizona Off to Fast Starts
Cleveland and Arizona Off to Fast Starts


Leave a Reply

 
© 2006-2017 BBNS.